Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription


14 Ann Intern Med
1 Biochem Biophys Res Commun
10 BMJ
2 Drug Saf
1 Epidemiol Infect
2 Eur J Epidemiol
1 J Exp Med
1 J Immunol
1 J Infect Dis
2 J Virol
5 Lancet
8 MMWR Morb Mortal Wkly Rep
3 N Engl J Med
7 Pediatrics
18 PLoS One
6 Proc Natl Acad Sci U S A
4 Vaccine

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Ann Intern Med

  1. KURIAKOSE S, Singh K, Pau AK, Daar E, et al
    Developing Treatment Guidelines During a Pandemic Health Crisis: Lessons Learned From COVID-19.
    Ann Intern Med. 2021 Jun 15. doi: 10.7326/M21-1647.
    PubMed         Abstract available

  2. MUSTAFA SS, Ramsey A, Staicu ML
    Administration of a Second Dose of the Moderna COVID-19 Vaccine After an Immediate Hypersensitivity Reaction With the First Dose: Two Case Reports.
    Ann Intern Med. 2021 Apr 6. doi: 10.7326/L21-0104.

  3. FOLLMANN D, Fintzi J, Fay MP, Janes HE, et al
    A Deferred-Vaccination Design to Assess Durability of COVID-19 Vaccine Effect After the Placebo Group Is Vaccinated.
    Ann Intern Med. 2021 Apr 13. doi: 10.7326/M20-8149.
    PubMed         Abstract available

  4. TOMKINS-TINCH CH, Daly JS, Gladden-Young A, Theodoropoulos NM, et al
    SARS-CoV-2 Reinfection in a Liver Transplant Recipient.
    Ann Intern Med. 2021 Apr 20. doi: 10.7326/L21-0108.

  5. NAU C, Bruxvoort K, Navarro RA, Chevez SG, et al
    COVID-19 Inequities Across Multiple Racial and Ethnic Groups: Results From an Integrated Health Care Organization.
    Ann Intern Med. 2021 Apr 20. doi: 10.7326/M20-8283.

    The Reign of the Ventilator: Acute Respiratory Distress Syndrome, COVID-19, and Technological Imperatives in Intensive Care.
    Ann Intern Med. 2021 May 4. doi: 10.7326/M21-0270.
    PubMed         Abstract available

  7. CHOU SH, McWilliams A, Murphy S, Sitammagari K, et al
    Factors Associated With Risk for Care Escalation Among Patients With COVID-19 Receiving Home-Based Hospital Care.
    Ann Intern Med. 2021 May 11. doi: 10.7326/M21-0409.

  8. PINELES BL, Goodman KE, Pineles L, O'Hara LM, et al
    In-Hospital Mortality in a Cohort of Hospitalized Pregnant and Nonpregnant Patients With COVID-19.
    Ann Intern Med. 2021 May 11. doi: 10.7326/M21-0974.

  9. ANAND S, Montez-Rath ME, Han J, Garcia P, et al
    Serial SARS-CoV-2 Receptor-Binding Domain Antibody Responses in Patients Receiving Dialysis.
    Ann Intern Med. 2021 May 18. doi: 10.7326/M21-0256.
    PubMed         Abstract available

  10. MACK CD, Osterholm M, Wasserman EB, Petruski-Ivleva N, et al
    Optimizing SARS-CoV-2 Surveillance in the United States: Insights From the National Football League Occupational Health Program.
    Ann Intern Med. 2021 Jun 15. doi: 10.7326/M21-0319.
    PubMed         Abstract available

  11. LAINE C, Cotton D
    COVID-19: Evaluation and Care of Patients With Persistent Symptoms Following Acute SARS-CoV-2 Infection.
    Ann Intern Med. 2021 Jun 11. doi: 10.7326/M21-2342.

  12. BILINSKI A, Salomon JA, Giardina J, Ciaranello A, et al
    Passing the Test: A Model-Based Analysis of Safe School-Reopening Strategies.
    Ann Intern Med. 2021 Jun 8. doi: 10.7326/M21-0600.
    PubMed         Abstract available

  13. TSAI Y, Vogt TM, Zhou F
    Patient Characteristics and Costs Associated With COVID-19-Related Medical Care Among Medicare Fee-for-Service Beneficiaries.
    Ann Intern Med. 2021 Jun 1. doi: 10.7326/M21-1102.
    PubMed         Abstract available

  14. QASEEM A, Yost J, Forciea MA, Jokela JA, et al
    The Development of Living, Rapid Practice Points: Summary of Methods From the Scientific Medical Policy Committee of the American College of Physicians.
    Ann Intern Med. 2021 May 25. doi: 10.7326/M20-7641.
    PubMed         Abstract available

    Biochem Biophys Res Commun

  15. OBA M, Rongduo W, Saito A, Okabayashi T, et al
    Natto extract, a Japanese fermented soybean food, directly inhibits viral infections including SARS-CoV-2 in vitro.
    Biochem Biophys Res Commun. 2021;570:21-25.
    PubMed         Abstract available


    Failure to prescribe: UK workers with occupational long covid-19 have been ignored.
    BMJ. 2021;374:n2018.

  17. HASSAN F, Yamey G, Abbasi K
    Profiteering from vaccine inequity: a crime against humanity?
    BMJ. 2021;374:n2027.

  18. BINGHAM R, Pickles H
    Prolonged solitary confinement of UK immigration detainees during the pandemic.
    BMJ. 2021;374:n2016.

    Intradermal covid-19 vaccination could solve supply problems.
    BMJ. 2021;374:n1980.

  20. CABEZAS C, Coma E, Mora-Fernandez N, Li X, et al
    Associations of BNT162b2 vaccination with SARS-CoV-2 infection and hospital admission and death with covid-19 in nursing homes and healthcare workers in Catalonia: prospective cohort study.
    BMJ. 2021;374:n1868.
    PubMed         Abstract available

  21. WILLIAMS SN, Yamey G
    How universities can make reopening safer this autumn.
    BMJ. 2021;374:n2019.

  22. CHUNG H, He S, Nasreen S, Sundaram ME, et al
    Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study.
    BMJ. 2021;374:n1943.
    PubMed         Abstract available

  23. RANZANI OT, Hitchings MDT, Dorion M, D'Agostini TL, et al
    Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated epidemic of covid-19 in Brazil: test negative case-control study.
    BMJ. 2021;374:n2015.
    PubMed         Abstract available

  24. MCCARTNEY M, Byng R
    Long covid clinics should be run as research hubs.
    BMJ. 2021;374:n1996.

  25. RIDER EA, Ansari E, Varrin PH, Sparrow J, et al
    Mental health and wellbeing of children and adolescents during the covid-19 pandemic.
    BMJ. 2021;374:n1730.

    Drug Saf

  26. MOORE N, Bosco-Levy P, Thurin N, Blin P, et al
    NSAIDs and COVID-19: A Systematic Review and Meta-analysis.
    Drug Saf. 2021;44:929-938.
    PubMed         Abstract available

  27. ROCCA E, Gauffin O, Savage R, Vidlin SH, et al
    Remdesivir in the COVID-19 Pandemic: An Analysis of Spontaneous Reports in VigiBase During 2020.
    Drug Saf. 2021;44:987-998.
    PubMed         Abstract available

    Epidemiol Infect

  28. MUSA OAH, Chivese T, Bansal D, Abdulmajeed J, et al
    Prevalence and determinants of symptomatic COVID-19 infection among children and adolescents in Qatar: a cross-sectional analysis of 11 445 individuals.
    Epidemiol Infect. 2021;149:e193.
    PubMed         Abstract available

    Eur J Epidemiol

  29. ESPENHAIN L, Tribler S, Svaerke Jorgensen C, Holm Hansen C, et al
    Prevalence of SARS-CoV-2 antibodies in Denmark: nationwide, population-based seroepidemiological study.
    Eur J Epidemiol. 2021;36:715-725.
    PubMed         Abstract available

  30. BELLUCO S, Mancin M, Marzoli F, Bortolami A, et al
    Prevalence of SARS-CoV-2 RNA on inanimate surfaces: a systematic review and meta-analysis.
    Eur J Epidemiol. 2021;36:685-707.
    PubMed         Abstract available

    J Exp Med

  31. RAPPE JCF, Finsterbusch K, Crotta S, Mack M, et al
    A TLR7 antagonist restricts interferon-dependent and -independent immunopathology in a mouse model of severe influenza.
    J Exp Med. 2021;218.
    PubMed         Abstract available

    J Immunol

  32. MA T, Ryu H, McGregor M, Babcock B, et al
    Protracted yet Coordinated Differentiation of Long-Lived SARS-CoV-2-Specific CD8(+) T Cells during Convalescence.
    J Immunol. 2021;207:1344-1356.
    PubMed         Abstract available

    J Infect Dis

  33. SUNTARATTIWONG P, Mott JA, Mohanty S, Sinthuwattanawibool C, et al
    Feasibility and Performance of Self-Collected Nasal Swabs for Detection of Influenza Virus, Respiratory Syncytial Virus, and Human Metapneumovirus.
    J Infect Dis. 2021;224:831-838.
    PubMed         Abstract available

    J Virol

  34. ABRAHAM M, Beavis AC, Xiao P, Villinger FJ, et al
    Evaluation of a new viral vaccine vector in mice and rhesus macaques: J paramyxovirus (JPV)-expressing HA of influenza A virus H5N1.
    J Virol. 2021 Sep 1:JVI0132121. doi: 10.1128/JVI.01321.
    PubMed         Abstract available

  35. WILLIAMS CM, Roy S, Califano D, McKenzie ANJ, et al
    IL-33-ILC2 axis represents a potential adjuvant target to increase the cross-protective efficacy of influenza vaccine.
    J Virol. 2021 Sep 1:JVI0059821. doi: 10.1128/JVI.00598.
    PubMed         Abstract available


  36. FRIEDEN TR, Lee CT, Bochner AF, Buissonniere M, et al
    7-1-7: an organising principle, target, and accountability metric to make the world safer from pandemics.
    Lancet. 2021;398:638-640.

  37. HIAM L, Yates R
    Will the COVID-19 crisis catalyse universal health reforms?
    Lancet. 2021 Jul 16. pii: S0140-6736(21)01650.

  38. CHAUHAN K, Soni D, Sarkar D, Karuna T, et al
    Mucormycosis after COVID-19 in a patient with diabetes.
    Lancet. 2021 Aug 4. pii: S0140-6736(21)01641.

    Haiti's health woes intensify.
    Lancet. 2021;398:567.

    Focusing on island health.
    Lancet. 2021;398:569-570.

    MMWR Morb Mortal Wkly Rep

  41. YIN S, Barnes K, Fisher R, Terashita D, et al
    COVID-19 Case Rates in Transitional Kindergarten Through Grade 12 Schools and in the Community - Los Angeles County, California, September 2020-March 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1220-1222.
    PubMed         Abstract available

  42. MURTHY BP, Zell E, Saelee R, Murthy N, et al
    COVID-19 Vaccination Coverage Among Adolescents Aged 12-17 Years - United States, December 14, 2020-July 31, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1206-1213.
    PubMed         Abstract available

  43. MATTHIAS J, Patrick S, Wiringa A, Pullman A, et al
    Epidemiologically Linked COVID-19 Outbreaks at a Youth Camp and Men's Conference - Illinois, June-July 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1223-1227.
    PubMed         Abstract available

  44. PINGALI C, Yankey D, Elam-Evans LD, Markowitz LE, et al
    National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:1183-1190.
    PubMed         Abstract available

  45. LAM-HINE T, McCurdy SA, Santora L, Duncan L, et al
    Outbreak Associated with SARS-CoV-2 B.1.617.2 (Delta) Variant in an Elementary School - Marin County, California, May-June 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1214-1219.
    PubMed         Abstract available

  46. BOEHMER TK, Kompaniyets L, Lavery AM, Hsu J, et al
    Association Between COVID-19 and Myocarditis Using Hospital-Based Administrative Data - United States, March 2020-January 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1228-1232.
    PubMed         Abstract available

  47. NERHOOD KJ, James ER, Hardin A, Bray JE, et al
    Screening Programs for SARS-CoV-2 Infections on a University Campus - Austin, Texas, September 30-November 30, 2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:1201-1205.
    PubMed         Abstract available

  48. DOYLE K, Teran RA, Reefhuis J, Kerins JL, et al
    Multiple Variants of SARS-CoV-2 in a University Outbreak After Spring Break - Chicago, Illinois, March-May 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1195-1200.
    PubMed         Abstract available

    N Engl J Med

  49. TEN CATE H
    Surviving Covid-19 with Heparin?
    N Engl J Med. 2021 Aug 4. doi: 10.1056/NEJMe2111151.

  50. LAWLER PR, Goligher EC, Berger JS, Neal MD, et al
    Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.
    N Engl J Med. 2021 Aug 4. doi: 10.1056/NEJMoa2105911.
    PubMed         Abstract available

  51. GOLIGHER EC, Bradbury CA, McVerry BJ, Lawler PR, et al
    Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.
    N Engl J Med. 2021 Aug 4. doi: 10.1056/NEJMoa2103417.
    PubMed         Abstract available


  52. ACKERSON BK, Sy LS, Glenn S, Qian L, et al
    Pediatric Vaccination During the COVID-19 Pandemic.
    Pediatrics. 2021 Apr 15. pii: peds.2020-047092. doi: 10.1542/peds.2020-047092.

  53. LELAK KA, Vohra V, Neuman MI, Farooqi A, et al
    COVID-19 and Pediatric Ingestions.
    Pediatrics. 2021;148.

  54. MAASSEL NL, Asnes AG, Leventhal JM, Solomon DG, et al
    Hospital Admissions for Abusive Head Trauma at Children's Hospitals During COVID-19.
    Pediatrics. 2021;148.

  55. LUGON P, Fuller T, Damasceno L, Calvet G, et al
    SARS-CoV-2 Infection Dynamics in Children and Household Contacts in a Slum in Rio de Janeiro.
    Pediatrics. 2021;148.
    PubMed         Abstract available

  56. COHEN JS, Donnelly K, Patel SJ, Badolato GM, et al
    Firearms Injuries Involving Young Children in the United States During the COVID-19 Pandemic.
    Pediatrics. 2021;148.
    PubMed         Abstract available

  57. DAVIS J, Gordon R, Hammond A, Perkins R, et al
    Rapid Implementation of Telehealth Services in a Pediatric Pulmonary Clinic During COVID-19.
    Pediatrics. 2021;148.
    PubMed         Abstract available

  58. CAMPBELL AP, Tokars JI, Reynolds S, Garg S, et al
    Influenza Antiviral Treatment and Length of Stay.
    Pediatrics. 2021 Sep 1. pii: peds.2021-050417. doi: 10.1542/peds.2021-050417.
    PubMed         Abstract available

    PLoS One

  59. HUI KY, Haines C, Bammann S, Hallandal M, et al
    To what extent is telehealth reported to be incorporated into undergraduate and postgraduate allied health curricula: A scoping review.
    PLoS One. 2021;16:e0256425.
    PubMed         Abstract available

  60. ERASO Y, Hills S
    Intentional and unintentional non-adherence to social distancing measures during COVID-19: A mixed-methods analysis.
    PLoS One. 2021;16:e0256495.
    PubMed         Abstract available

  61. KUO PF, Chiu CS
    Airline transportation and arrival time of international disease spread: A case study of Covid-19.
    PLoS One. 2021;16:e0256398.
    PubMed         Abstract available

  62. HADIANFAR A, Yousefi R, Delavary M, Fakoor V, et al
    Effects of government policies and the Nowruz holidays on confirmed COVID-19 cases in Iran: An intervention time series analysis.
    PLoS One. 2021;16:e0256516.
    PubMed         Abstract available

  63. VALVERDE-BERROCOSO J, Fernandez-Sanchez MR, Revuelta Dominguez FI, Sosa-Diaz MJ, et al
    The educational integration of digital technologies preCovid-19: Lessons for teacher education.
    PLoS One. 2021;16:e0256283.
    PubMed         Abstract available

  64. ALNAJJAR S, Sitthicharoenchai P, Gallup J, Ackermann M, et al
    Streptococcus pneumoniae serotype 22F infection in respiratory syncytial virus infected neonatal lambs enhances morbidity.
    PLoS One. 2021;16:e0235026.
    PubMed         Abstract available

  65. SHERWANI RAK, Shakeel H, Saleem M, Awan WB, et al
    A new neutrosophic sign test: An application to COVID-19 data.
    PLoS One. 2021;16:e0255671.
    PubMed         Abstract available

  66. CHANDRA R, Krishna A
    COVID-19 sentiment analysis via deep learning during the rise of novel cases.
    PLoS One. 2021;16:e0255615.
    PubMed         Abstract available

  67. TICHOPAD A, Pecen L, Sedlak V
    Could the new coronavirus have infected humans prior November 2019?
    PLoS One. 2021;16:e0248255.
    PubMed         Abstract available

  68. LAL R, Huang W, Li Z
    An application of the ensemble Kalman filter in epidemiological modelling.
    PLoS One. 2021;16:e0256227.
    PubMed         Abstract available

  69. LI J, Zhao M, She H, Chandra A, et al
    The impact of the COVID-19 pandemic lockdown on rhegmatogenous retinal detachment services-Experiences from the Tongren eye center in Beijing.
    PLoS One. 2021;16:e0254751.
    PubMed         Abstract available

  70. COSTA VO, Nicolini EM, da Costa BMA, Ferreira VHP, et al
    Sociodemographic, laboratory, image data and predictors of gravity risk in patients with COVID-19.
    PLoS One. 2021;16:e0256331.
    PubMed         Abstract available

  71. DIMAI S, Semmler L, Prabhu A, Stachelscheid H, et al
    COVID19-associated cardiomyocyte dysfunction, arrhythmias and the effect of Canakinumab.
    PLoS One. 2021;16:e0255976.
    PubMed         Abstract available

  72. ALMANZA-REYES H, Moreno S, Plascencia-Lopez I, Alvarado-Vera M, et al
    Evaluation of silver nanoparticles for the prevention of SARS-CoV-2 infection in health workers: In vitro and in vivo.
    PLoS One. 2021;16:e0256401.
    PubMed         Abstract available

  73. KALAM MA, Davis TP Jr, Shano S, Uddin MN, et al
    Exploring the behavioral determinants of COVID-19 vaccine acceptance among an urban population in Bangladesh: Implications for behavior change interventions.
    PLoS One. 2021;16:e0256496.
    PubMed         Abstract available

  74. SUNTRONWONG N, Vichaiwattana P, Wongsrisang L, Klinfueng S, et al
    Prevalence of antibodies against seasonal influenza A and B viruses among older adults in rural Thailand: A cross-sectional study.
    PLoS One. 2021;16:e0256475.
    PubMed         Abstract available

  75. DE TONI G, Consonni C, Montresor A
    A general method for estimating the prevalence of influenza-like-symptoms with Wikipedia data.
    PLoS One. 2021;16:e0256858.
    PubMed         Abstract available

  76. MCKITRICK M, Schuurman N, Crooks VA, Snyder J, et al
    Spatial and temporal patterns in Canadian COVID-19 crowdfunding campaigns.
    PLoS One. 2021;16:e0256204.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  77. MARANI M, Katul GG, Pan WK, Parolari AJ, et al
    Intensity and frequency of extreme novel epidemics.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  78. SULLIVAN O, Gershuny J, Sevilla A, Foliano F, et al
    Using time-use diaries to track changing behavior across successive stages of COVID-19 social restrictions.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  79. ANDREANO E, Piccini G, Licastro D, Casalino L, et al
    SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  80. KLUVER H, Hartmann F, Humphreys M, Geissler F, et al
    Incentives can spur COVID-19 vaccination uptake.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  81. MIRABELLI C, Wotring JW, Zhang CJ, McCarty SM, et al
    Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  82. CHAMAKURI S, Lu S, Ucisik MN, Bohren KM, et al
    DNA-encoded chemistry technology yields expedient access to SARS-CoV-2 M(pro) inhibitors.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available


  83. JOGI P, Soeorg H, Ingerainen D, Soots M, et al
    Prevalence of SARS-CoV-2 IgG antibodies and their association with clinical symptoms of COVID-19 in Estonia (KoroSero-EST-1 study).
    Vaccine. 2021;39:5376-5384.
    PubMed         Abstract available

  84. GRUPEL D, Gazit S, Schreiber L, Nadler V, et al
    Kinetics of SARS-CoV-2 anti-S IgG after BNT162b2 vaccination.
    Vaccine. 2021 Aug 11. pii: S0264-410X(21)01045.
    PubMed         Abstract available

    Implementing vaccination policies based upon scientific evidence in Japan.
    Vaccine. 2021 Aug 7. pii: S0264-410X(21)00968.
    PubMed         Abstract available

  86. O'LORCAIN P, Cotter S, Walsh C
    Influenza vaccine uptake among healthcare workers and residents in public health care facilities in Ireland over nine influenza seasons (2011-2012 to 2019-2020).
    Vaccine. 2021 Aug 27. pii: S0264-410X(21)00987.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.